Despite the potential of IL-2, the use of high-dose IL-2 is limited due to severe associated toxicities, such as hypotension, pulmonary edema, and renal failure, which restrict its broader clinical use [157–162]. This evidence concerns the gene IL2 and Renal insufficiency.